# A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)

> **NCT00168792** · PHASE4 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 1671 (—)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Tenecteplase
- **PROCEDURE:** PCI

## Key facts

- **NCT ID:** NCT00168792
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-11
- **Primary completion:** 2006-07
- **Final completion:** —
- **Target enrollment:** 1671 (—)
- **Last updated:** 2013-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168792, "A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00168792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*